Related Experiment Video
Updated: Jun 26, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Performance of the St. Jude Medical Riata leads
Andrew E Epstein1, James H Baker, Scott L Beau
1Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294-0006, USA. aepstein@uab.edu
Insights
The incidence of adverse events for St. Jude Medical Riata implantable cardioverter-defibrillator (ICD) leads is rare. This study found low rates of conductor fracture, insulation damage, dislodgement, and perforation in over 7,000 patients.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Device Performance
Background:
- High-voltage implantable cardioverter-defibrillator (ICD) lead performance is under scrutiny.
- Lead-related adverse events stem from various factors like patient traits, therapies, implantation methods, access site, and lead design.
- Limited studies possess the patient numbers and follow-up duration to accurately assess ICD lead performance and adverse event incidence.
Purpose of the Study:
- To determine the incidence of lead-related adverse events for St. Jude Medical Riata ICD leads.
- Specifically investigate conductor fracture, insulation damage, perforation, and dislodgement.
Main Methods:
- Analysis of data from four prospective registries and clinical trials: Advancements in ICD Therapy, OPTIMUM, RHYTHM, and PAS.
- Inclusion of 7,497 patients implanted with Riata leads.
- Median follow-up of 22 months, recording adverse events requiring lead revision, extraction, or replacement.
Main Results:
- Conductor fracture incidence: 0.09%.
- Insulation damage incidence: 0.13%.
- Lead dislodgement incidence: 0.88%.
- Perforation incidence: 0.31%.
Conclusions:
- The incidence of lead-related adverse events (conductor fracture, insulation damage, dislodgement, perforation) requiring intervention for St. Jude Medical Riata ICD leads is rare.
- Findings based on over 7,000 leads and a median follow-up exceeding 22 months across multiple prospective studies.
Background:
Recent attention has been focused on the performance of high-voltage implantable cardioverter-defibrillator (ICD) leads. Lead-related adverse events can be caused by several factors, including patient characteristics, concomitant therapies, implantation technique, access site, and lead design. Few studies have included the number of patients and the follow-up duration necessary to characterize accurately the lead performance and the incidence of lead-related adverse events.
Objective:
This study sought to define the incidence of lead-related adverse events including conductor fracture, insulation damage, perforation, and dislodgement of St. Jude Medical Riata ICD leads.
Methods:
Data from the Advancements in ICD Therapy, OPTIM Lead InsUlation Material (OPTIMUM), Resynchronization HemodYnamic Treatment for Heart Failure Management (RHYTHM), and Post Approval Study (PAS) registries provided data from 7,497 patients with Riata leads. Patients were followed up for a median of 22 months. Adverse events, defined as those that required lead revision, extraction, or replacement, were recorded.
Results:
Conductor fracture occurred in 0.09%, insulation damage in 0.13%, dislodgement in 0.88%, and perforation in 0.31% of patients, respectively.
Conclusion:
During more than 22 months of follow-up of over 7,000 Riata leads in 4 prospective registries and clinical trials, the incidence of lead-related adverse events including conductor fracture, insulation damage, dislodgement, and perforation necessitating lead revision, extraction, or replacement is rare.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization IV: Nursing Management
Mitral Stenosis III: Medical Management
Cardiopulmonary Resuscitation III: AED Use
Cardiac Catheterization I: Pre-Procedure Overview